Microbial Therapeutics in Cancer
Probiotics, prebiotics, synbiotics, and postbiotics—what they can (and can’t) do in integrative cancer care
Cancer care is evolving, and one of the most promising frontiers is not a new drug, but an ecosystem: the microbiome.
A recent topical review, Microbial Therapeutics in Cancer: Translating Probiotics, Prebiotics, Synbiotics, and Postbiotics from Mechanistic Insights to Clinical Applications, summarizes how “PPSPs” (probiotics, prebiotics, synbiotics, and postbiotics) may influence cancer biology and treatment response through immune modulation, barrier integrity, inflammatory signaling, and metabolite production.
Why this matters to our clinic
At Katallage Wellness, we do not administer chemotherapy. Instead, we focus on a whole approach to biology such as metabolic and immune-supportive oncology care, including IV Mistletoe and Ozone therapy, IV nutrient programs, ketogenic metabolic therapy, and targeted supplementation, while coordinating with a patient’s oncology team for diagnostics and standard-of-care decisions when appropriate.
The microbiome lens helps us answer a practical question:
How do we strengthen the terrain—immune resilience, metabolic stability, gut integrity—so patients tolerate their journey better and reduce avoidable inflammatory burden?
What “microbial therapeutics” actually means
The journal review outlines several microbiome-based approaches:
Probiotics: live organisms intended to confer a health benefit
Prebiotics: fermentable substrates (often fibers/polyphenols) that feed beneficial microbes
Synbiotics: combinations of probiotics + prebiotics
Postbiotics: non-living microbial products/metabolites (or inactivated microbes) that may still signal beneficial effects
Mechanistically, these interventions are discussed as potential tools to influence immune signaling and inflammation, strengthen mucosal barriers, and shape microbial metabolites that affect systemic physiology.
The functional medicine application: “precision, not hype”
In cancer care, microbiome work has to be careful and individualized. “More probiotics” is not inherently better. Strains matter. Dose matters. Timing matters. Host factors matter.
In our clinic, the microbiome approach typically sits inside a broader plan that includes:
1) Barrier-first nutrition
Even before supplements, we stabilize the foundations: protein adequacy, hydration/electrolytes, glycemic stability, and gut-friendly fibers—when appropriate. For many patients, we use a ketogenic metabolic therapy framework (tailored to goals and tolerance), which can reduce glucose volatility and support metabolic steadiness during times of physiologic stress.
2) Prebiotics and polyphenols as “food-first microbial therapeutics”
For many patients, the most reliable and safe microbial support starts with prebiotic fibers and polyphenols—because they shape microbial outputs without introducing live organisms. This can be especially helpful when immune status is complex; keeping it simple and just eating the right foods to provide what you need.
3) Probiotics only when the “terrain” is right
Some patients benefit from targeted probiotic trials—especially after antibiotics, with diarrhea patterns, or when there is a clear symptom target. In immune-compromised states, probiotic selection requires extra caution.
4) Postbiotics: a promising category
Postbiotics are especially interesting because they may offer signaling benefits without requiring live organisms. A postbiotic is not a live bacterium. It’s the helpful “product” made by good microbes that can still benefit the gut and immune system, using the “beneficial signal” without adding living organisms. An example is butyrate, often sold as sodium butyrate or tributyrin. Butyrate is a short-chain fatty acid your gut bacteria make when they ferment fiber. It helps nourish the cells lining the colon and supports gut barrier function.
Where IV therapy fits: supporting redox and resilience
Microbiome strategies work best when the body has the biochemical capacity to respond. That’s one reason we often pair gut-focused strategies with targeted IV programs that support antioxidant systems and amino acid.
Our bottom line
The microbiome is not a cancer “cure,” but it is increasingly recognized as a meaningful lever in cancer biology and clinical experience. The most responsible application is measured and personalized: food-first where possible, targeted supplementation where appropriate, and aligned with the patient’s broader oncologic plan.
If you’re navigating cancer care and want metabolic + gut-immune support: our team can help build a plan that integrates ketogenic strategies, IV nutrient support, and carefully selected microbiome tools—without sensational claims, and with respect for your full medical picture.